Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
Susan E. Dorman(Medical University of South Carolina), Soumitesh Chakravorty(Rutgers, The State University of New Jersey), Camilla Rodrigues(P. D. Hinduja Hospital and Medical Research Centre), Wilfred Murithi(Kenya Medical Research Institute), Alena Skrahina(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Claudia M. Denkinger(Heidelberg University), Renata Lyrio Peres(Universidade Federal do Espírito Santo), Nestani Tukvadze(National Center for Tuberculosis and Lung Disease), Lesley Scott(National Health Laboratory Service), Derek T. Armstrong(Johns Hopkins University), Yonas Ghebrekristos(National Health Laboratory Service), Samuel G. Schumacher(University of Rostock), Wendy Stevens(University of Namur), Mahmud Hanif, Sandra L. Hall(Boston University), Catharina Boehme(FIND), Nino Bablishvili(National Center for Tuberculosis and Lung Disease), Irene Anyango(Kenya Medical Research Institute), Reynaldo Dietze(Universidade Federal do Espírito Santo), David Alland(Rutgers, The State University of New Jersey), Moses Joloba(Ministry of Health), Jerrold J. Ellner(Rutgers, The State University of New Jersey), Lydia Nakiyingi(Makerere University), Vera Auchynka(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Mark P. Nicol(The University of Western Australia), Daniela María Cirillo(Vita-Salute San Raffaele University), Xin Liu(Beijing Radiation Center), Xing Yuan(Henan Provincial Chest Hospital), Bonnie King(Johns Hopkins University), Kamal Kishore Chopra, Mubin Kazi(P. D. Hinduja Hospital and Medical Research Centre), Pamela Nabeta(FIND)
Cited by 688
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis
|European Respiratory Journal|2014|532
Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2
|New England Journal of Medicine|2010|526